Pharma Focus Asia

Bora Pharmaceuticals Expands Sterile Manufacturing Facility in Maryland, USA

Introduction:

Bora Pharmaceuticals plans for the expansion of sterile manufacturing facility in Maryland, USA to provide Sterile Fill/Finish Services.
 
Features: 

The newly acquired 87,000-square-foot facility specialises in manufacturing drug products for sterile injectables. 

It offers comprehensive clinical and commercial services for non-viral aseptic fill/finish operations across four production lines. These capabilities encompass lyophilisation, vial filling, and pre-filled syringe filling, catering to a range of pharmaceutical needs.

This expansion initiative aims to bolster its presence in North America by enhancing capabilities in sterile drug product manufacturing. 

This expansion enables the facility to expand its capabilities to include both drug substance and drug product manufacturing. It synergistically complements the existing development and manufacturing services tailored for biologics developers.

The hugely talented team at the facility supports sterile drug product manufacturing.

Specifications:

Name    Bora Pharmaceuticals
Type      Expansion

 

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference